Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.46 |
| ▸ | GRM8 | O00222 | 4/20 | 0.46 |
| ▸ | GRM6 | O15303 | 2/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | CETP | P11597 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55394 | 0.88 | FOLH1 (0.49) | GRM4GRM8GRM6FOLH1CETP | |
| SCHEMBL56051 | 0.87 | FOLH1 (0.46) | GRM4GRM8GRM6FOLH1CETP | |
| SCHEMBL56343 | 0.85 | GRM4 (0.57) | SLC7A5GRM4GRM8GRM6FOLH1 | |
| SCHEMBL21189181 | 0.83 | GRM4 (0.46) | SLC7A5GRM4GRM8GRM6 | |
| SCHEMBL56061 | 0.78 | GRM4 (0.58) | GRM4GRM8GRM6FOLH1CETP | |
| SCHEMBL56601 | 0.77 | SLC1A5 (0.46) | GRM4GRM8GRM6FOLH1CETP | |
| SCHEMBL57236 | 0.76 | GRM8 (0.62) | GRM4GRM8GRM6CETP | |
| SCHEMBL21189162 | 0.75 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6 | |
| SCHEMBL21189163 | 0.75 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6 | |
| SCHEMBL21189140 | 0.75 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008137446-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY DISEASE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2008-11-13 | — | — | WO | claimed |
| EP-4291301-A1 | NON-INVASIVE CANCER TREATMENT | Scientia Biotech S.L. (ES) | 2023-12-20 | — | — | EP | disclosed |
| WO-2022171826-A1 | NON-INVASIVE CANCER TREATMENT | SCIENTIA BIOTECH S.L (ES) | 2022-08-18 | — | — | WO | disclosed |
| EP-4043071-A1 | NON-INVASIVE CANCER TREATMENT | Scientia Biotech S.L. (ES) | 2022-08-17 | — | — | EP | disclosed |
| US-11179348-B2 | Combination comprising pterostilbene for the treatment of cancer | FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR (ES) | 2021-11-23 | — | — | US | disclosed |
| EP-3368025-A1 | COMBINATION COMPRISING PTEROSTILBENE FOR THE TREATMENT OF CANCER | Fundación Universidad Católica de Valencia San Vicente Mártir (ES) | 2018-09-05 | — | — | EP | disclosed |
| US-20180214390-A1 | COMBINATION COMPRISING PTEROSTILBENE FOR THE TREATMENT OF CANCER | UNIVERSITAT DE VALÈNCIA - ESTUDI GENERAL (ES) | 2018-08-02 | — | — | US | disclosed |
| WO-2017012774-A1 | COMBINATION COMPRISING PTEROSTILBENE FOR THE TREATMENT OF CANCER | FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR (ES) | 2017-01-26 | — | — | WO | disclosed |
| US-8129557-B2 | Phosphonic acid diester derivative and method for producing thereof | Nagai, Kazuhiro (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | HIRATAKE, GOU (JP) | 2009-06-25 | — | — | US | disclosed |
| WO-2008137446-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY DISEASE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2008-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180214390-A1 | COMBINATION COMPRISING PTEROSTILBENE FOR THE TREATMENT OF CANCER | GSTP1, GGT1, GSTA1 | SLC7A5 866/4885GRM4 1140/4885GRM8 1178/4885 |
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | PPA1, G6PD, PHOSPHO1 | SLC7A5 3382/4885GRM4 4122/4885GRM8 4595/4885 |
| US-11179348-B2 | Combination comprising pterostilbene for the treatment of cancer | GSTP1, GGT1, GSTA1 | SLC7A5 866/4885GRM4 1140/4885GRM8 1178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.